Geng-Xi Cai (Gengxi Cai)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Sentinel Lymph Node

Neoadjuvant Chemotherapy

Top Venues

Cell death discovery

JCO precision oncology

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Geng-Xi Cai, Wei-Yao Kong, Yuan Liu, Shu-Yi Zhong, Qing Liu, Yuan-Fei Deng, Guo-Lin Ye
Nuclear transport maintenance of USP22-AR by Importin-7 promotes breast cancer progression. Cell death discovery 9 (1) (2023)
Geng-Xi Cai, Wei-Yao Kong, Yuan Liu, Shu-Yi Zhong, Qing Liu, Yuan-Fei Deng, Guo-Lin Ye
Nuclear transport maintenance of USP22-AR by Importin-7 promotes breast cancer progression. Cell death discovery 9 (1) (2023)
Geng-Xi Cai, Wei-Yao Kong, Yuan Liu, Shu-Yi Zhong, Qing Liu, Yuan-Fei Deng, Guo-Lin Ye
Nuclear transport maintenance of USP22-AR by Importin-7 promotes breast cancer progression. Cell death discovery 9 (1) (2023)
Geng-Xi Cai, Zhanwen Guan, Yabin Jin, Zuhui Su, Xiangping Chen, Qing Liu, Chunlin Wang, Xiaoxia Yin, Lifang Zhang, Guolin Ye, Wei Luo
Circulating T-Cell Repertoires Correlate With the Tumor Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy. JCO precision oncology 6 (2022)
Xu Yang, Geng-Xi Cai, Bo-Wei Han, Zhi-Wei Guo, Ying-Song Wu, Xiao-Ming Lyu, Li-Min Huang, Yuan-Bin Zhang, Xin Li, Guo-Lin Ye, Xue-Xi Yang
Association between the nucleosome footprint of plasma DNA and neoadjuvant chemotherapy response for breast cancer. NPJ breast cancer 7 (1) (2021)